You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 14, April 8, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  The World in Medicine
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Vitamin K Supplements

Rebecca Voelker, JAMA contributor

JAMA. 1998;279:1058.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Vitamin K should be considered in the growing list of micronutrients being added to foods to prevent deficiency diseases in children of poor nations, according to a new report.

In the February issue of the American Journal of Public Health, researchers from Brazil and the United States recommend that vitamin K supplementation in foods and possibly in BCG vaccine should be investigated to prevent severe hemorrhagic disease in newborns in the least developed nations. Severe hemorrhagic disease has a case fatality rate of 14%, but about 40% of infants who survive have long-term neurologic handicaps, the researchers noted.

The researchers estimate that the incidence of severe hemorrhagic disease is about 28 per 100000 births in less developed nations, compared with 7 per 100000 births in industrialized countries. Even though the incidence is small in some areas, the researchers said the consequences are so severe and . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.